AINDEX
Markets

Smith & Nephew plc (SNN)

SNNNYSEIndustrial Specialties

$30.92

-0.1300 (-0.42%) today

Closed, Nov 10, 4:00 PM ET

-0.42% 1D
Market cap
$12.95bn
P/E
–
EPS, last 4 quarters
–
Dividend yield
–
Day range
–
52-week range
$26.12 to $37.09
Average volume
413.9k
Previous close
$31.05

Analysts

4 covering

Hold0 buy, 4 hold, 0 sell

Targets a year out average $33.44, +8.2% from here

$33.00now $30.92$33.88

Earnings

Next report

Financials

No quarterly figures from the source.

News

8 latest

The company

Smith+Nephew is a portfolio medical technology business focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people's bodies and their self-belief by using technology to take the limits off living. We call this purpose 'Life Unlimited'. Our 17,000 employees deliver this mission every day, making a difference to patients' lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global business units of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Founded in Hull, UK, in 1856, we now operate in around 100 countries, and generated annual sales of $6.2 billion in 2025. Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN). The terms 'Group' and 'Smith+Nephew' are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise.

Sector
Health Care
Industry
Industrial Specialties
Exchange
NYSE
Region
Europe
Website
smith-nephew.com

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.

Smith & Nephew plc (SNN) price, chart and news · AINDEX